AU637720B2 - Substituted-4-amino-3-pyridinols, a process for their preparation and their use as medicaments - Google Patents

Substituted-4-amino-3-pyridinols, a process for their preparation and their use as medicaments

Info

Publication number
AU637720B2
AU637720B2 AU84756/91A AU8475691A AU637720B2 AU 637720 B2 AU637720 B2 AU 637720B2 AU 84756/91 A AU84756/91 A AU 84756/91A AU 8475691 A AU8475691 A AU 8475691A AU 637720 B2 AU637720 B2 AU 637720B2
Authority
AU
Australia
Prior art keywords
loweralkyl
chem
hydrogen
preparation
pyridinols
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
AU84756/91A
Other languages
English (en)
Other versions
AU8475691A (en
Inventor
Nicholas Joseph Hrib
John Gerard Jurcak
Kevin James Kapples
Gregory Michael Shutske
John Dick Tomer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Roussel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharmaceuticals Inc filed Critical Hoechst Roussel Pharmaceuticals Inc
Publication of AU8475691A publication Critical patent/AU8475691A/en
Application granted granted Critical
Publication of AU637720B2 publication Critical patent/AU637720B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Surface Treatment Of Glass (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU84756/91A 1990-09-27 1991-09-26 Substituted-4-amino-3-pyridinols, a process for their preparation and their use as medicaments Expired - Fee Related AU637720B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58911390A 1990-09-27 1990-09-27
US589113 1990-09-27

Publications (2)

Publication Number Publication Date
AU8475691A AU8475691A (en) 1992-04-02
AU637720B2 true AU637720B2 (en) 1993-06-03

Family

ID=24356648

Family Applications (1)

Application Number Title Priority Date Filing Date
AU84756/91A Expired - Fee Related AU637720B2 (en) 1990-09-27 1991-09-26 Substituted-4-amino-3-pyridinols, a process for their preparation and their use as medicaments

Country Status (22)

Country Link
US (3) US5821239A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0477903B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP3090511B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR100215357B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE136297T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU637720B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2052433C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CZ (1) CZ282002B6 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE69118470T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK0477903T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2085940T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI914504A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR3019742T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HUT60247A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE73874B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL99581A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO913778L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ239935A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT99073B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW200462B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (1) YU158591A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA917692B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
FR2813891B1 (fr) * 2000-09-14 2005-01-14 Immunotech Sa Reactif multifonctionnel pour erythrocytes mettant en jeu des carbamates et applications
DE10102791B4 (de) * 2001-01-22 2004-04-15 Ifm Electronic Gmbh Elektrischer Meßumformer
IL162270A0 (en) * 2001-12-14 2005-11-20 Novo Nordisk As Compounds and uses thereof for decreasing activityof hormone-sensitive lipase
KR100443983B1 (ko) 2002-01-15 2004-08-09 삼성전자주식회사 냉장고
US8007826B2 (en) * 2003-12-11 2011-08-30 Acorda Therapeutics, Inc. Sustained release aminopyridine composition
US8354437B2 (en) 2004-04-09 2013-01-15 Acorda Therapeutics, Inc. Method of using sustained release aminopyridine compositions
EP2607362B1 (en) * 2005-02-17 2014-12-31 Astellas Pharma Inc. Piperidine and piperazine carboxylates as FAAH inhibitors
BRPI0903914A2 (pt) * 2008-09-10 2015-07-21 Acorda Therapeutics Inc Uso de um composto, método para analisar a eficácia de uma composição de liberação prolongada, e, composição farmacêutica.
BR112012019923A2 (pt) 2010-02-09 2016-08-09 Univ Johns Hopkins métodos e composições para melhorar a função cognitiva
HK1215170A1 (zh) 2012-11-14 2016-08-19 The Johns Hopkins University 治療精神分裂症的方法和組合物
CN104853755B (zh) 2012-12-13 2017-08-22 H.隆德贝克有限公司 包含沃替西汀和多奈哌齐的组合物
EP2968237A4 (en) 2013-03-15 2016-08-31 Univ Johns Hopkins METHOD AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
CN105142623A (zh) 2013-03-15 2015-12-09 艾吉因生物股份有限公司 用于改善认知功能的方法和组合物
MX384391B (es) 2015-05-22 2025-03-14 Agenebio Inc Composiciones farmacéuticas de levetiracetam de liberación extendida.

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2562288A (en) * 1987-11-17 1989-05-18 Ici Americas Inc. Heterocyclic substituted imino derivatives
AU603265B2 (en) * 1987-10-29 1990-11-08 Ici Americas Inc. Fungicidal pyridyl cyclopropane carboxamidines
AU5784790A (en) * 1989-06-28 1991-01-03 Hoechst-Roussel Pharmaceuticals Incorporated Naphthylamio- and naphthyloxy-pyridinamines and related compounds,a process for their preparation and their use as dermatological agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179563A (en) * 1978-05-19 1979-12-18 Warner-Lambert Company 3-Aryloxy-substituted-aminopyridines and methods for their production
US4734275A (en) * 1983-08-19 1988-03-29 Research Corporation Anti-curare agents
DE3514073A1 (de) * 1985-04-18 1986-10-23 Hoechst Ag, 6230 Frankfurt Mehrfach substituierte pyridin-1-oxide, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
US4735958A (en) * 1986-12-22 1988-04-05 Warner-Lambert Company Trans-6-[2-[2-(substituted-phenyl)-3- (or 4-) heteroaryl-5-substituted-1H-pyrrol-1-yl]-ethyl]tetrahydro-4-hydroxy-2H-pyran-2-one inhibitors of cholesterol biosynthesis
US5019574A (en) * 1988-09-30 1991-05-28 Chugai Seiyaku Kabushiki Kaisha 3,4-diaminoquinoline and 3,4-diamino-5,6,7,8-tetrahydroquinoline compounds useful for improving psychoneural function
DE68906647T2 (de) * 1988-11-16 1993-10-07 Hoechst Roussel Pharma Hydroxy-1,2,3,4-tetrahydroaminoacridine, Verfahren für ihre Herstellung und ihre Verwendung als Arzneimittel.

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU603265B2 (en) * 1987-10-29 1990-11-08 Ici Americas Inc. Fungicidal pyridyl cyclopropane carboxamidines
AU2562288A (en) * 1987-11-17 1989-05-18 Ici Americas Inc. Heterocyclic substituted imino derivatives
AU5784790A (en) * 1989-06-28 1991-01-03 Hoechst-Roussel Pharmaceuticals Incorporated Naphthylamio- and naphthyloxy-pyridinamines and related compounds,a process for their preparation and their use as dermatological agents

Also Published As

Publication number Publication date
PT99073B (pt) 1999-02-26
DE69118470D1 (de) 1996-05-09
ES2085940T3 (es) 1996-06-16
YU158591A (sh) 1994-12-28
US5821239A (en) 1998-10-13
FI914504A7 (fi) 1992-03-28
EP0477903B1 (en) 1996-04-03
DK0477903T3 (da) 1996-07-29
NZ239935A (en) 1995-07-26
KR100215357B1 (ko) 1999-08-16
GR3019742T3 (en) 1996-07-31
JPH04261157A (ja) 1992-09-17
DE69118470T2 (de) 1996-09-19
US5869480A (en) 1999-02-09
HU913075D0 (en) 1992-01-28
HUT60247A (en) 1992-08-28
CA2052433A1 (en) 1992-03-28
NO913778D0 (no) 1991-09-26
CA2052433C (en) 2003-04-15
AU8475691A (en) 1992-04-02
US5866565A (en) 1999-02-02
ATE136297T1 (de) 1996-04-15
PT99073A (pt) 1992-08-31
EP0477903A3 (en) 1992-08-05
IE73874B1 (en) 1997-07-02
EP0477903A2 (en) 1992-04-01
ZA917692B (en) 1992-05-27
NO913778L (no) 1992-03-30
CZ282002B6 (cs) 1997-04-16
JP3090511B2 (ja) 2000-09-25
FI914504A0 (fi) 1991-09-25
IE913389A1 (en) 1992-04-08
IL99581A (en) 1995-07-31
TW200462B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-02-21
CS293691A3 (en) 1992-04-15
KR920006318A (ko) 1992-04-27
IL99581A0 (en) 1992-08-18

Similar Documents

Publication Publication Date Title
AU637720B2 (en) Substituted-4-amino-3-pyridinols, a process for their preparation and their use as medicaments
AU635575B2 (en) 4- and 6-carbamates related to physostigmine, a process and intermediates for their preparation and their use as medicaments
CA2111461A1 (en) 3-Aminopiperidine Derivatives and Related Nitrogen Containing Heterocycles
HU9201887D0 (en) Process for the production of //aralkyl-piperidine-4-yl/-methyl/-2a,3,4,5-tetrahydro-1-/2h/-acenaphtylene-1-on derivatives and of medical preparations containing them as active agents
EP0648760A3 (en) Triazine derivatives, process for their preparation and their use.
TW207539B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR3005461T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HUT72897A (en) Indole derivatives having antitumor activity and pharmaceutical composition containing them